Restoration of erectile capacity in normotensive aged rats by modulation of angiotensin receptor type 1

Journal of Andrology

Volumn 26, Issue 1, 2005, Pages 123-128

  Park, Kwanjin ^a   Jae, Wook Shin ^b   Jin, Kyu Oh ^b   Kyong, Shin Ryu ^b   Soo, Woong Kim ^b   Paick, Jae Seung ^b,c  

^a Cancer Center Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Erectile dysfunction; Losartan; Sprague Dawley rat

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; APOMORPHINE; DRUG VEHICLE; LOSARTAN; LOSARTAN POTASSIUM; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ERECTILE DYSFUNCTION; IMMUNOBLOTTING; LIPID PEROXIDATION; MALE; MODULATION; NONHUMAN; OXIDATIVE STRESS; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

AGING; ANIMALS; ANTIHYPERTENSIVE AGENTS; APOMORPHINE; BLOOD PRESSURE; BLOTTING, WESTERN; DOPAMINE AGONISTS; IMPOTENCE; LIPID PEROXIDATION; LOSARTAN; MALE; PENILE ERECTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 10844226689     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Akingba AG, Burnett AL. Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan-induced diabetic rat. Mol Urol. 2001;5:189-197.
2. Becker AJ, Uckert S, Stief CG, Scheller F, Knapp WH, Hartmann U, Jonas U. Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology. 2001;58:805-810.
3. Cartledge JJ, Eardley I, Morrison JF. Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes. BJU Int. 2001;87:394-401.
4. Champion HC, Bivalacqua TJ, Hyman AL, Ignarro LJ, Hellstrom WJ, Kadowitz PJ. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci U S A. 1999;116:48-52.
5. Christ GJ, Stone B, Melman A. Age-dependent alterations in the efficacy of phenylephrine-induced contractions in vascular smooth muscle isolated from the corpus cavernosum of impotent men. Can J Physiol Pharmacol. 1991;69:909-913.
6. Chung WS, Park YY, Kwon SW. The impact of aging on penile hemodynamics in normal responders to pharmacological injection: a Doppler sonographic study. J Urol. 1997;157:2129-2131.
7. Dahiya R, Chui R, Perinchery G, Nakajima K, Oh BR, Lue TF. Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction. Int J Impot Res. 1999;11:201-206.
8. Devereux RB, Dahlof B, Kjeldsen SE, et al. Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial. Ann Intern Med. 2003;139:169-177.
9. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61.
10. Hale TM, Okabe H, Bushfield TL, Heaton JP, Adams MA. Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol. 2002;168:348-354.
11. Iwamoto Y, Song K, Takai S, Yamada M, Jin D, Sakaguchi M. Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum. J Pharmacol Exp Ther. 2001;298:43-48.
12. Kansui Y, Fujii K, Goto K, Abe I, Iida M. Angiotensin II receptor antagonist improves age-related endothelial dysfunction. J Hypertens. 2002;20:439-446.
13. Kifor I, Williams GH, Vickers MA, Sullivan MP, Jodbert P, Dluhy RG. Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. J Urol. 1997;157:1920-1925.
14. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
15. Manabe K, Heaton JP, Morales A, Kumon H, Adams MA. Pre-penile arteries are dominant in the regulation of penile vascular resistance in the rat. Int J Impot Res. 2000;12:183-189.
16. Rajasekaran M, Kasyan A, Jain A, Kim SW, Monga M. Altered growth factor expression in the aging penis: the Brown-Norway rat model. J Androl. 2002;23:393-399.
17. Seftel AD. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment. J Urol. 2003;169:1999-2007.
18. Tarcan T, Azadzoi KM, Siroky MB, Goldstein I, Krane RJ. Age-related erectile and voiding dysfunction: the role of arterial insufficiency. Br J Urol. 1998;82:26-33.
19. Weber MA. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease. Rev Cardiovasc Med. 2002;3:183-191.
20. Wespes E. Smooth muscle pathology and erectile dysfunction. Int J Impot Res. 2002;14(suppl 1):S17-S21.